Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Kamali

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|May 10, 2026
Complications following small-molecule inhibitors for non-small cell lung cancerCaroline Kamali, Simon Ekman
Cancers|July 10, 2020
ALK-Brain Prognostic Index-Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain MetastasesGeorgios Tsakonas, Caroline Kamali, Luigi De Petris, et al.
Translational Lung Cancer Research|December 13, 2024
Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center studyCaroline Kamali, Georgios Tsakonas, Per Hydbring, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centersIoannis Zerdes, Caroline Kamali, Berglind Johannsdottir, et al.
JTO Clinical and Research Reports|June 4, 2026
Risk Factors for Developing Venous Thromboembolism in Patients With Advanced ALK-Rearranged NSCLCCaroline Kamali, Georgios Tsakonas, Rolf Lewensohn, et al.
Cancers|March 6, 2021
Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCRChristiane Stiller, Kristina Viktorsson, Elizabeth Paz Gomero, et al.
Molecular Oncology|March 26, 2021
Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stageBo Franzén, Kristina Viktorsson, Caroline Kamali, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|May 10, 2026
Complications following small-molecule inhibitors for non-small cell lung cancerCaroline Kamali, Simon Ekman
Cancers|July 10, 2020
ALK-Brain Prognostic Index-Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain MetastasesGeorgios Tsakonas, Caroline Kamali, Luigi De Petris, et al.
Translational Lung Cancer Research|December 13, 2024
Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center studyCaroline Kamali, Georgios Tsakonas, Per Hydbring, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centersIoannis Zerdes, Caroline Kamali, Berglind Johannsdottir, et al.
JTO Clinical and Research Reports|June 4, 2026
Risk Factors for Developing Venous Thromboembolism in Patients With Advanced ALK-Rearranged NSCLCCaroline Kamali, Georgios Tsakonas, Rolf Lewensohn, et al.
Cancers|March 6, 2021
Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCRChristiane Stiller, Kristina Viktorsson, Elizabeth Paz Gomero, et al.
Molecular Oncology|March 26, 2021
Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stageBo Franzén, Kristina Viktorsson, Caroline Kamali, et al.
Pageof 1